ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2022

Cost-Effectiveness of Tumor Genomic Profiling to Guide First-Line Targeted Therapy Selection in Patients With Metastatic Lung Adenocarcinoma.

Olivia M Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.